However, our findings that As3+ mediates the abnormal expression of CD71 and CD235a during erythroid expansion, may provide useful information for further investigations on the molecular mechanism by which As3+ exposure impairs multiple stages of erythropoiesis and causes anemia. The gene discussed is TFRC; the disease is anemia.